Lenox Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-64
Closed -$5K 855
2021
Q4
$5K Buy
64
+18
+39% +$1.24K ﹤0.01% 599
2021
Q3
$3K Hold
46
﹤0.01% 600
2021
Q2
$3K Hold
46
﹤0.01% 612
2021
Q1
$3K Sell
46
-139
-75% -$8.96K ﹤0.01% 569
2020
Q4
$11K Buy
185
+72
+64% +$4.34K ﹤0.01% 409
2020
Q3
$7K Sell
113
-66
-37% -$4.58K ﹤0.01% 409
2020
Q2
$14K Buy
179
+113
+171% +$8.66K ﹤0.01% 337
2020
Q1
$5K Buy
+66
New +$4.56K ﹤0.01% 423
2019
Q4
Sell
-253
Closed -$16K 759
2019
Q3
$16K Buy
+253
New +$16.5K ﹤0.01% 315
2018
Q1
Sell
-961
Closed -$69K 551
2017
Q4
$69K Buy
+961
New +$73K 0.02% 91
2017
Q2
Sell
-51
Closed -$3K 107
2017
Q1
$3K Buy
+51
New +$3.59K ﹤0.01% 81
2016
Q1
Sell
-65
Closed -$7K 316
2015
Q4
$7K Sell
65
-202
-76% -$21K ﹤0.01% 197
2015
Q3
$26K Buy
267
+202
+311% +$22.4K 0.01% 121
2015
Q2
$8K Hold
65
﹤0.01% 162
2015
Q1
$6K Sell
65
-400
-86% -$40.6K ﹤0.01% 214
2014
Q4
$44K Buy
465
+65
+16% +$6.72K 0.02% 91
2014
Q3
$43K Sell
400
-59
-13% -$5.78K 0.02% 90
2014
Q2
$40K Buy
459
+59
+15% +$4.59K 0.02% 77
2014
Q1
$29K Sell
400
-105
-21% -$8.23K 0.02% 80
2013
Q4
$38K Buy
505
+105
+26% +$7.31K 0.03% 79
2013
Q3
$25K Hold
400
0.02% 52
2013
Q2
$21K Buy
+400
New +$20.8K 0.02% 68

Other funds holding GILD

Lenox Wealth Advisors's GILD Position: Q1 2022 in Review

Lenox Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 64 shares — an estimated $5K sold.

Lenox Wealth Advisors first reported a position in GILD in Q2 2013 and held it in 22 quarters. The position peaked at $69K in Q4 2017. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Lenox Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Lenox Wealth Advisors sold 64 Gilead Sciences shares in Q1 2022, an estimated $5K.
  • Lenox Wealth Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 22 quarters.
  • Lenox Wealth Advisors's Gilead Sciences position peaked at $69K in Q4 2017.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.